TD Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.9M Buy
133,053
+81,513
+158% +$41.7M 0.05% 259
2025
Q4
$28.9M Sell
51,540
-76,607
-60% -$43.5M 0.02% 433
2025
Q3
$65.9M Sell
128,147
-329,498
-72% -$144M 0.05% 265
2025
Q2
$144M Buy
457,645
+61,764
+16% +$18.5M 0.12% 152
2025
Q1
$121M Sell
395,881
-68,080
-15% -$22.9M 0.11% 168
2024
Q4
$154M Sell
463,961
-39,113
-8% -$13.3M 0.14% 147
2024
Q3
$167M Sell
503,074
-8,194
-2% -$3.11M 0.15% 140
2024
Q2
$211M Sell
511,268
-62,881
-11% -$24.9M 0.2% 118
2024
Q1
$232M Buy
574,149
+107,108
+23% +$37.7M 0.22% 108
2023
Q4
$143M Buy
467,041
+308,816
+195% +$83.4M 0.14% 138
2023
Q3
$38.3M Sell
158,225
-13,505
-8% -$3.45M 0.05% 301
2023
Q2
$41.2M Sell
171,730
-32,886
-16% -$6.83M 0.05% 306
2023
Q1
$38.5M Sell
204,616
-31,132
-13% -$6.44M 0.05% 306
2022
Q4
$50.1M Sell
235,748
-49,489
-17% -$9.89M 0.06% 255
2022
Q3
$44.5M Buy
285,237
+19,442
+7% +$3.1M 0.06% 269
2022
Q2
$39.8M Buy
265,795
+16,829
+7% +$2.44M 0.05% 301
2022
Q1
$40.7M Buy
248,966
+9,071
+4% +$1.5M 0.04% 326
2021
Q4
$52.2M Sell
239,895
-2,019
-0.8% -$423K 0.04% 318
2021
Q3
$45.8M Sell
241,914
-1,014
-0.4% -$185K 0.05% 299
2021
Q2
$42.7M Buy
242,928
+40,815
+20% +$7.04M 0.04% 320
2021
Q1
$33.2M Buy
+202,113
New +$30.9M 0.04% 360
2020
Q3
Sell
-5,400
Closed -$502K 1378
2020
Q2
$502K Sell
5,400
-7,400
-58% -$630K ﹤0.01% 1213
2020
Q1
$939K Buy
+12,800
New +$1.11M ﹤0.01% 1016

Other funds holding MEDP

TD Asset Management's MEDP Position: Q1 2026 in Review

TD Asset Management increased its Medpace (MEDP) stake by 158% in Q1 2026, buying an estimated $41.7M and bringing the position to 133,053 shares worth $63.9M. The position accounts for 0.05% of the portfolio, ranked #259.

TD Asset Management first reported a position in MEDP in Q1 2020 and has held it in 23 quarters since. The position peaked at $232M in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • TD Asset Management held 133,053 shares of Medpace worth $63.9M as of Q1 2026.
  • TD Asset Management bought 81,513 Medpace shares in Q1 2026, an estimated $41.7M.
  • Medpace made up 0.05% of TD Asset Management's portfolio in Q1 2026, its #259 holding.
  • TD Asset Management first reported a position in Medpace in Q1 2020 and has held it in 23 quarters since.
  • TD Asset Management's Medpace position peaked at $232M in Q1 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.